Total Funding
30
Total FundingSeries B raised
Growth Score
pts
Heat Score
-20 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
949681
PainCeptor Pharma Inc., a Montreal-based drug company focused on the treatment of chronic and acute pain.
About the Company
PainCeptor Pharma is a pharmaceutical company developing next generation
therapeutic drugs for the treatment of chronic and acute pain. PainCeptor's
therapeutic programs are concentrated on some of the most promising, novel,
yet scientifically validated therapeutic targets within the PNS (peripheral
nervous system). By focusing on
modulating target receptors in the PNS,
PainCeptor expects to enhance the efficacy and avoid the many detrimental side
effects associated with today's pain drugs which act primarily in the CNS
(central nervous system). PainCeptor's development pipeline includes two lead
antagonist programs, targeting NGF/p75-TrkA and ASIC1a, and a third antagonist
program targeting ASIC3.
